Skip to content
2000
image of Current Research Focus and Trends of Remimazolam: A Bibliometric Analysis of the 100 Most Cited Articles

Abstract

Introduction

Remimazolam is a novel benzodiazepine derivative with advantages such as prompt onset, short duration of action, fast recovery, and non-organ dependence. Numerous studies have been conducted on remimazolam. However, bibliometric analysis on high-quality and highly cited articles related to remimazolam is lacking. The objective of this article is to evaluate the current research status and prevailing trends regarding the most frequently cited articles on remimazolam, utilizing bibliometrics.

Methods

Studies related to remimazolam were searched in the Web of Science core database. The search period ranged from the inception of the database to April 2025, and 100 highly cited research articles were selected. The researchers gathered and analyzed pertinent data from the studies and subsequently conducted visual analysis utilizing VOSviewer and CiteSpace.

Results

The total number of citations for the top 100 highly cited studies was 6683, published between 2010 and 2024. China, the United States, and the United Kingdom contributed the majority of these studies. These studies were published in 47 different journals. The journal with the highest number of publications was the . The institution with the highest publication volume was PAION DEUTSCHLAND GMBH in Germany, and the author with the highest contribution was Schippers F. The pharmacokinetics, pharmacodynamics, safety, and efficacy of remimazolam were the main research directions and focuses in the field.

Discussion

Our analysis of the top 100 cited remimazolam papers reveals a rapidly advancing field. The surge in high-quality clinical studies confirms remimazolam's practical edge over older agents, such as propofol, particularly in offering better blood pressure stability for older patients and fewer breathing problems during procedures like endoscopy. While these advantages position it as a strong contender, important questions linger about its use in people with severe liver or kidney issues due to how it is broken down, and its effects on delirium remain unclear. Broadening research globally and focusing on these specific patient groups, as well as long-term safety, will be key to realizing remimazolam's full clinical potential.

Conclusion

This study analyzed the 100 most frequently referenced articles on remimazolam, providing valuable insights into the characteristics and focal areas of research related to this topic.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X370775250704060228
2025-07-24
2025-11-04

  • From This Site

    /content/journals/cn/10.2174/011570159X370775250704060228
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Monanian G. Yonel B. Rupert D. Razak A. DeLemos M. Bergese S.D. Evaluating remimazolam for procedural sedation. Curr. Neuropharmacol. 2025 23 9 1009 1020 10.2174/011570159X367968250117034551 39936418
    [Google Scholar]
  2. Hu Q. Liu X. Wen C. Li D. Lei X. Remimazolam: An updated review of a new sedative and anaesthetic. Drug Des. Devel. Ther. 2022 16 3957 3974 10.2147/DDDT.S384155 36411859
    [Google Scholar]
  3. Kilpatrick G.J. Remimazolam: Non-clinical and clinical profile of a new sedative/anesthetic agent. Front. Pharmacol. 2021 12 690875 10.3389/fphar.2021.690875 34354587
    [Google Scholar]
  4. Sneyd J.R. Remimazolam – current status, opportunities and challenges. Anesthesiol. Perioperative Sci. 2023 1 3 25 10.1007/s44254‑023‑00021‑7
    [Google Scholar]
  5. Chang Y. Huang Y.T. Chi K.Y. Huang Y.T. Remimazolam versus propofol for procedural sedation: A meta-analysis of randomized controlled trials. PeerJ 2023 11 e15495 10.7717/peerj.15495 37334113
    [Google Scholar]
  6. Zhao M. Hu H. Li X. Li X. Wang D. Kuang M. The safety and efficacy between remimazolam and propofol in intravenous anaesthesia of endoscopy operation: A systematic review and meta-analysis. Int. J. Surg. 2023 109 11 3566 3577 10.1097/JS9.0000000000000638 37534687
    [Google Scholar]
  7. Dou D. Feng Y. Jiang L. Efficiency and safety of remimazolam and midazolam in digestive endoscopic sedation: Systematic review and meta‐analysis. Dig. Endosc. 2022 34 3 653 10.1111/den.14219 34918386
    [Google Scholar]
  8. Kim S.H. Cho J.Y. Kim M. Chung J.M. Yang J. Seong C. Kim E.G. Seok J.W. Shin Y.M. Lee K.M. Choe K.H. Han J.H. Yang B. Safety and efficacy of remimazolam compared with midazolam during bronchoscopy: A single-center, randomized controlled study. Sci. Rep. 2023 13 1 20498 10.1038/s41598‑023‑47271‑w 37993525
    [Google Scholar]
  9. Zhang X. Li H.X. Chen Y.R. Wang B.N. Zheng H. Yan T. Safety and efficacy of remimazolam compared with propofol for general anesthesia during cold knife conization: A single-center, randomized controlled trial. BMC Anesthesiol. 2025 25 1 197 10.1186/s12871‑025‑03066‑2 40269691
    [Google Scholar]
  10. Wang Z. Zhan R. Mo L. Zhang J. Hu J. Tan S. He Q. Li P. Sun W. Wang X. Jiang J. Liu L. Zhang Y. Bai Y. Comparison of effect of remimazolam and propofol on respiration of patients under deep sedation for colonoscopy: A prospective multicenter randomized controlled trial. Eur. J. Med. Res. 2025 30 1 250 10.1186/s40001‑025‑02519‑1 40189570
    [Google Scholar]
  11. Xin Y. Lu P. Guan S. Si S. Sun R. Xia W. Xu H. Efficacy and safety of remimazolam in short endoscopic procedures: A systematic review and meta-analysis. Medicina (Kaunas) 2025 61 3 453 10.3390/medicina61030453 40142264
    [Google Scholar]
  12. Kilpatrick G.J. McIntyre M.S. Cox R.F. Stafford J.A. Pacofsky G.J. Lovell G.G. Wiard R.P. Feldman P.L. Collins H. Waszczak B.L. Tilbrook G.S. CNS 7056: A novel ultra-short-acting Benzodiazepine. Anesthesiology 2007 107 1 60 66 10.1097/01.anes.0000267503.85085.c0 17585216
    [Google Scholar]
  13. Keam S.J. Remimazolam: First approval. Drugs 2020 80 6 625 633 10.1007/s40265‑020‑01299‑8 32274703
    [Google Scholar]
  14. Administration N.M.P. Annual Report on Drug Review. 2019 Available from [https://www.nmpa.gov.cn/]
    [Google Scholar]
  15. Min J.J. Oh E.J. Hwang H.J. Jo S. Cho H. Kim C. Lee J.H. Hypotension after induction of anesthesia with remimazolam or etomidate: A non-inferiority randomized controlled trial in patients undergoing coronary artery bypass grafting. Korean J. Anesthesiol. 2025 78 2 139 147 10.4097/kja.24537 39748752
    [Google Scholar]
  16. Horikoshi Y. Kuratani N. Tateno K. Hoshijima H. Nakamura T. Mieda T. Doi K. Nagasaka H. Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy. Medicine (Baltimore) 2021 100 49 e28209 10.1097/MD.0000000000028209 34889305
    [Google Scholar]
  17. Petkus H. Willer B.L. Tobias J.D. Remimazolam in a pediatric patient with a suspected family history of malignant hyperthermia. J. Med. Cases 2022 13 8 386 390 10.14740/jmc3977 36128061
    [Google Scholar]
  18. Zhu K. Wu S. Hao X. Wang C. Successful sedation with remimazolam and alfentanil in a child susceptible to malignant hyperthermia: A case report. BMC Anesthesiol. 2025 25 1 207 10.1186/s12871‑025‑03076‑0 40269725
    [Google Scholar]
  19. Yang X. Lin C. Chen S. Huang Y. Cheng Q. Yao Y. Remimazolam for the prevention of emergence delirium in children following tonsillectomy and adenoidectomy under sevoflurane anesthesia: A randomized controlled study. Drug Des. Devel. Ther. 2022 16 3413 3420 10.2147/DDDT.S381611 36203819
    [Google Scholar]
  20. Brüggemann V. Hansen T.G. Remimazolam for sedation and anesthesia in children: Protocol for a scoping review. Acta Anaesthesiol. Scand. 2024 68 6 848 851 10.1111/aas.14411 38504555
    [Google Scholar]
  21. Zhou T. Qu J. Sun H. Xue M. Shen Y. Liu Y. Research trends and hotspots on montessori intervention in patients with dementia from 2000 to 2021: A bibliometric analysis. Front. Psychiatry 2021 12 737270 10.3389/fpsyt.2021.737270 34566730
    [Google Scholar]
  22. Li T. Yang A. Liu G. Zou S. Chen Y. Ni B. Liu Y. Fan J. Status quo and research trends of craniopharyngioma research: A 10-year bibliometric analyses (From 2011 to 2020). Front. Oncol. 2021 11 744308 10.3389/fonc.2021.744308 34660308
    [Google Scholar]
  23. Abushamma F. Barqawi A. Al-Jabi S.W. Akkawi M. Maree M. Zyoud S.H. Global analysis of research trends on kidney function after nephron-sparing surgery: A bibliometric and visualised study. Cancer Manag. Res. 2021 13 7479 7487 10.2147/CMAR.S324284 34611441
    [Google Scholar]
  24. Ninkov A. Frank J.R. Maggio L.A. Bibliometrics: Methods for studying academic publishing. Perspect. Med. Educ. 2021 11 3 173 176 10.1007/S40037‑021‑00695‑4 34914027
    [Google Scholar]
  25. Yi K. Xu J.G. Yang K.L. Zhang X. Ma L. You T. Tian J.H. The top-100 most cited articles of biomarkers in congenital heart disease: A bibliometric analysis. Ann. Palliat. Med. 2022 11 5 1700 1713 10.21037/apm‑21‑2422 35016519
    [Google Scholar]
  26. Powell A.G.M.T. Hughes D.L. Wheat J.R. Lewis W.G. The 100 most influential manuscripts in gastric cancer: A bibliometric analysis. Int. J. Surg. 2016 28 83 90 10.1016/j.ijsu.2016.02.028 26873521
    [Google Scholar]
  27. Vaishya R. Gupta B.M. Misra A. Mamdapur G.M.N. Walke R. Vaish A. Top 100 highly cited papers from India on COVID-19 research: A bibliometric analysis of the core literature. Diabetes Metab. Syndr. 2023 17 11 102898 10.1016/j.dsx.2023.102898 37952296
    [Google Scholar]
  28. Wan Z. Wang T. Lu P. Shu C. Bibliometric analysis of the top 100 most-cited articles on branch reconstruction in endovascular aortic repair. Asian J. Surg. 2024 47 1 486 496 10.1016/j.asjsur.2023.06.124 37423856
    [Google Scholar]
  29. Chen L. Li N. Zhang Y. High-impact papers in the field of anesthesiology: A 10-year cross-sectional study. Can. J. Anaesth. 2023 70 2 183 190 10.1007/s12630‑022‑02363‑5 36418743
    [Google Scholar]
  30. Hu X. Wang B. Hu L. Han D. Wu J. Bibliometric analysis of global trends in remimazolam-related research over the past 15 years: Compared with propofol. Drug Des. Devel. Ther. 2023 17 2119 2135 10.2147/DDDT.S411829 37496748
    [Google Scholar]
  31. Godin B.J.S. On the origins of bibliometrics. Scientometrics 2006 68 1 109 133 10.1007/s11192‑006‑0086‑0
    [Google Scholar]
  32. Lee A. Shirley M. Remimazolam: A review in procedural sedation. Drugs 2021 81 10 1193 1201 10.1007/s40265‑021‑01544‑8 34196946
    [Google Scholar]
  33. Wang Z. Hu Z. Dai T. The comparison of propofol and midazolam for bronchoscopy. Medicine (Baltimore) 2018 97 36 e12229 10.1097/MD.0000000000012229 30200147
    [Google Scholar]
  34. Triantafillidis J.K. Merikas E. Nikolakis D. Papalois A.E. Sedation in gastrointestinal endoscopy: Current issues. World J. Gastroenterol. 2013 19 4 463 481 10.3748/wjg.v19.i4.463 23382625
    [Google Scholar]
  35. Cohen L.B. Wecsler J.S. Gaetano J.N. Benson A.A. Miller K.M. Durkalski V. Aisenberg J. Endoscopic sedation in the United States: Results from a nationwide survey. Am. J. Gastroenterol. 2006 101 5 967 974 10.1111/j.1572‑0241.2006.00500.x 16573781
    [Google Scholar]
  36. Froehlich F. Harris J. Wietlisbach V. Burnand B. Vader J.P. Gonvers J.J. Current sedation and monitoring practice for colonoscopy: An International Observational Study (EPAGE). Endoscopy 2006 38 5 461 469 10.1055/s‑2006‑925368 16767580
    [Google Scholar]
  37. Vargo J.J. DeLegge M.H. Feld A.D. Gerstenberger P.D. Kwo P.Y. Lightdale J.R. Nuccio S. Rex D.K. Schiller L.R. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastrointest. Endosc. 2012 76 1 e1 e25 10.1016/j.gie.2012.03.001 22624793
    [Google Scholar]
  38. Mui L. Teoh A.Y.B. Ng E.K.W. Lee Y. Au Yeung A.C.M. Chan Y. Lau J.Y.W. Chung S.C.S. Premedication with orally administered midazolam in adults undergoing diagnostic upper endoscopy: A double-blind placebo-controlled randomized trial. Gastrointest. Endosc. 2005 61 2 195 200 10.1016/S0016‑5107(04)02590‑8 15729225
    [Google Scholar]
  39. Cohen L.B. Hightower C.D. Wood D.A. Miller K.M. Aisenberg J. Moderate level sedation during endoscopy: A prospective study using low-dose propofol, meperidine/fentanyl, and midazolam. Gastrointest. Endosc. 2004 59 7 795 803 10.1016/S0016‑5107(04)00349‑9 15173791
    [Google Scholar]
  40. Vargo J.J. Zuccaro G. Dumot J.A. Morrow J.B. Conwell D.L. Trolli P.A. Shermock K.M. Maurer W.G. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: A prospective, randomized trial. Gastroenterology 2002 123 1 8 16 10.1053/gast.2002.34232 12105827
    [Google Scholar]
  41. Ulmer B.J. Hansen J.J. Overley C.A. Symms M.R. Chadalawada V. Liangpunsakul S. Strahl E. Mendel A.M. Rex D.K. Propofol versus midazolam/fentanyl for outpatient colonoscopy: Administration by nurses supervised by endoscopists. Clin. Gastroenterol. Hepatol. 2003 1 6 425 432 10.1016/S1542‑3565(03)00226‑X 15017641
    [Google Scholar]
  42. Sipe B.W. Rex D.K. Latinovich D. Overley C. Kinser K. Bratcher L. Kareken D. Propofol versus midazolam/meperidine for outpatient colonoscopy: Administration by nurses supervised by endoscopists. Gastrointest. Endosc. 2002 55 7 815 825 10.1067/mge.2002.124636 12024134
    [Google Scholar]
  43. Madan H.K. Singh R. Sodhi G.S. Comparsion of intravenous lignocaine, tramadol and keterolac for attenuation of propofol injection pain. J. Clin. Diagn. Res. 2016 10 7 UC05 UC08 10.7860/JCDR/2016/20444.8118 27630928
    [Google Scholar]
  44. Marik P. Propofol: Therapeutic indications and side-effects. Curr. Pharm. Des. 2004 10 29 3639 3649 10.2174/1381612043382846 15579060
    [Google Scholar]
  45. Pastis N.J. Yarmus L.B. Schippers F. Ostroff R. Chen A. Akulian J. Wahidi M. Shojaee S. Tanner N.T. Callahan S.P. Feldman G. Lorch D.G. Ndukwu I. Pritchett M.A. Silvestri G.A. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest 2019 155 1 137 146 10.1016/j.chest.2018.09.015 30292760
    [Google Scholar]
  46. Rex D.K. Bhandari R. Desta T. DeMicco M.P. Schaeffer C. Etzkorn K. Barish C.F. Pruitt R. Cash B.D. Quirk D. Tiongco F. Sullivan S. Bernstein D. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest. Endosc. 2018 88 3 427 437.e6 10.1016/j.gie.2018.04.2351 29723512
    [Google Scholar]
  47. Pambianco D.J. Borkett K.M. Riff D.S. Winkle P.J. Schwartz H.I. Melson T.I. Wilhelm-Ogunbiyi K. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest. Endosc. 2016 83 5 984 992 10.1016/j.gie.2015.08.062 26363333
    [Google Scholar]
  48. Worthington M.T. Antonik L.J. Goldwater D.R. Lees J.P. Wilhelm-Ogunbiyi K. Borkett K.M. Mitchell M.C. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth. Analg. 2013 117 5 1093 1100 10.1213/ANE.0b013e3182a705ae 24108261
    [Google Scholar]
  49. Chen S. Wang J. Xu X. Huang Y. Xue S. Wu A. Jin X. Wang Q. Lyu J. Wang S. Li Y. Yu Y. Ai D. Luo A. Min S. Li L. Zou X. Liu J. Lv P. Chai X. Sun X. Zhao Z. Zhang J. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: A multicentered, randomized, positive-controlled, phase III clinical trial. Am. J. Transl. Res. 2020 12 8 4594 4603 [PMID: 32913533
    [Google Scholar]
  50. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab. Rev. 2009 41 2 67 76 10.1080/03602530902722679 19514965
    [Google Scholar]
  51. Lim B.G. Lee I.O. Anesthetic management of geriatric patients. Korean J. Anesthesiol. 2020 73 1 8 29 10.4097/kja.19391 31636241
    [Google Scholar]
  52. Kuang Q. Zhong N. Ye C. Zhu X. Wei F. Propofol versus remimazolam on cognitive function, hemodynamics, and oxygenation during one-lung ventilation in older patients undergoing pulmonary lobectomy: A randomized controlled trial. J. Cardiothorac. Vasc. Anesth. 2023 37 10 1996 2005 10.1053/j.jvca.2023.06.027 37422336
    [Google Scholar]
  53. Hu B. Jiang K. Shi W. Xiao S. Zhang S. Zhang Y. Zhou Y. Tan C. Tan S. Zou X. Effect of remimazolam tosilate on respiratory depression in elderly patients undergoing gastroscopy: A multicentered, prospective, and randomized study. Drug Des. Devel. Ther. 2022 16 4151 4159 10.2147/DDDT.S391147 36506792
    [Google Scholar]
  54. Tian Y. Chen D. Zhang H. Sun Y. Comparative analysis of the therapeutic efficacy of remimazolam tosylate and propofol in older adults undergoing painless endoscopic retrograde cholangiopancreatography. Front. Pharmacol. 2024 15 1404536 10.3389/fphar.2024.1404536 39484164
    [Google Scholar]
  55. Jeon Y.G. Kim S. Park J.H. Lee J. Song S.A. Lim H.K. Song S.W. Incidence of intraoperative hypotension in older patients undergoing total intravenous anesthesia by remimazolam versus propofol: A randomized controlled trial. Medicine (Baltimore) 2023 102 49 e36440 10.1097/MD.0000000000036440 38065872
    [Google Scholar]
  56. Chai B. Guo J. Xu Z. Chen T. Wang H. Zhu Z. Zhong J. Chen K. Du J. Kang X. Comparison of the efficacy and safety of remimazolam and propofol for fiberoptic bronchoscopy in older patients: A prospective, randomized controlled study. BMC Geriatr. 2025 25 1 337 10.1186/s12877‑025‑05984‑9 40369438
    [Google Scholar]
  57. Lu Y. Wu J. Lan H. Xu Q. Shi S. Duan G. Efficacy and safety of general anesthesia induction with ciprofol in hip fracture surgery of elderly patients: A randomized controlled trial. Drug Des. Devel. Ther. 2024 18 3951 3958 10.2147/DDDT.S475176 39247794
    [Google Scholar]
  58. Cao Y. Chi P. Zhou C. Lv W. Quan Z. Xue F.S. Errate: Remimazolam tosilate sedation with adjuvant sufentanil in chinese patients with liver cirrhosis undergoing gastroscopy: A randomized controlled study. Med. Sci. Monit. 2022 28 e938399 10.12659/MSM.938399 36111483
    [Google Scholar]
  59. Guo J. Qian Y. Zhang X. Han S. Shi Q. Xu J. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022 22 1 180 10.1186/s12871‑022‑01713‑6 35689208
    [Google Scholar]
  60. Choe J.W. Chung M.J. Park S.W. Oh D. Han S.Y. Yang M.J. Kim E.J. Cho J.H. Lee K.J. Jang S.I. Safety and efficacy of remimazolam versus propofol during EUS: a multicenter randomized controlled study. Gastrointest. Endosc. 2024 100 2 183 191.e1 10.1016/j.gie.2024.04.001 38580132
    [Google Scholar]
  61. Ko C.C. Hung K.C. Illias A.M. Chiu C.C. Yu C.H. Lin C.M. Chen I.W. Sun C.K. The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis. Front. Pharmacol. 2023 14 1101728 10.3389/fphar.2023.1101728 36814492
    [Google Scholar]
  62. Antonik L.J. Goldwater D.R. Kilpatrick G.J. Tilbrook G.S. Borkett K.M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesth. Analg. 2012 115 2 274 283 10.1213/ANE.0b013e31823f0c28 22190555
    [Google Scholar]
  63. Song J. Yu W. Chen S. Huang J. Zhou C. Liang H. Remimazolam attenuates inflammation and kidney fibrosis following folic acid injury. Eur. J. Pharmacol. 2024 966 176342 10.1016/j.ejphar.2024.176342 38290569
    [Google Scholar]
  64. Shi F. Chen Y. Li H. Zhang Y. Zhao T. Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation. Int. J. Gen. Med. 2022 15 583 591 10.2147/IJGM.S345390 35046716
    [Google Scholar]
  65. Uchida S. Takekawa D. Hashiba E. Kudo R. Hirota K. Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report. JA Clin. Rep. 2022 8 1 99 10.1186/s40981‑022‑00590‑9 36572840
    [Google Scholar]
  66. Stöhr T. Colin P.J. Ossig J. Pesic M. Borkett K. Winkle P. Struys M.M.R.F. Schippers F. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br. J. Anaesth. 2021 127 3 415 423 10.1016/j.bja.2021.05.027 34246461
    [Google Scholar]
  67. Mao Q. Liang B. Leng Z. Ma W. Chen Y. Xie Y. Remimazolam ameliorates postoperative cognitive dysfunction after deep hypothermic circulatory arrest through HMGB1-TLR4-NF-κB pathway. Brain Res. Bull. 2024 217 111086 10.1016/j.brainresbull.2024.111086 39322086
    [Google Scholar]
  68. Zhou Z. Yang Y. Wei Y. Xie Y. Remimazolam attenuates lps-derived cognitive dysfunction via subdiaphragmatic vagus nerve target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. Neurochem. Res. 2024 49 5 1306 1321 10.1007/s11064‑024‑04115‑x 38472553
    [Google Scholar]
  69. Zhou L. Shi H. Xiao M. Liu W. Wang L. Zhou S. Chen S. Wang Y. Liu C. Remimazolam attenuates lipopolysaccharide-induced neuroinflammation and cognitive dysfunction. Behav. Brain Res. 2025 476 115268 10.1016/j.bbr.2024.115268 39322063
    [Google Scholar]
  70. Yang J.J. Lei L. Qiu D. Chen S. Xing L.K. Zhao J.W. Mao Y.Y. Yang J.J. Effect of remimazolam on postoperative delirium in older adult patients undergoing orthopedic surgery: A prospective randomized controlled clinical trial. Drug Des. Devel. Ther. 2023 17 143 153 10.2147/DDDT.S392569 36712948
    [Google Scholar]
  71. Cai Y.H. Zhong J.W. Ma H.Y. Szmuk P. Wang C.Y. Wang Z. Zhang X.L. Dong L.Q. Liu H.C. Effect of remimazolam on emergence delirium in children undergoing laparoscopic surgery: A double-blinded randomized trial. Anesthesiology 2024 141 3 500 510 10.1097/ALN.0000000000005077 38758221
    [Google Scholar]
  72. Terres M.T. Assis M.L. Da Silveira C.B. Amaral S. Remimazolam versus propofol for endoscopy sedation in elderly patients: A systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiol. 2024 90 9 775 784 10.23736/S0375‑9393.24.18027‑3 38775443
    [Google Scholar]
  73. Zhu H. Su Z. Zhou H. Lu J. Wang X. Ji Z. Chen S. Wang X. Yao M. Lu Y. Yu W. Su D. Remimazolam dosing for gastroscopy: A randomized noninferiority trial. Anesthesiology 2024 140 3 409 416 10.1097/ALN.0000000000004851 38039392
    [Google Scholar]
  74. Jhuang B.J. Yeh B.H. Huang Y.T. Lai P.C. Efficacy and safety of remimazolam for procedural sedation: A meta-analysis of randomized controlled trials with trial sequential analysis. Front. Med. (Lausanne) 2021 8 641866 10.3389/fmed.2021.641866 34386505
    [Google Scholar]
  75. Sneyd J.R. Rigby-Jones A.E. Remimazolam for anaesthesia or sedation. Curr. Opin. Anaesthesiol. 2020 33 4 506 511 10.1097/ACO.0000000000000877 32530890
    [Google Scholar]
/content/journals/cn/10.2174/011570159X370775250704060228
Loading
Current Research Focus and Trends of Remimazolam: A Bibliometric Analysis of the 100 Most Cited Articles
Bentham Science Publishers ; https://doi.org/10.2174/011570159X370775250704060228
/content/journals/cn/10.2174/011570159X370775250704060228
/content/journals/cn/10.2174/011570159X370775250704060228
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: VOSviewer ; Bibliometric analysis ; bibliometrics ; remimazolam ; CiteSpace ; Web of Science ; most-cited articles

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test